Financial Toxicity in Cancer Patients Treated with Radiotherapy – a jDEGRO Confirmatory Cross-Sectional Study
- Conditions
- C80.9Malignant neoplasm, primary site unspecified
- Registration Number
- DRKS00028784
- Lead Sponsor
- niversitätsklinikum Schleswig-Holstein Campus Kiel
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 1075
Inclusion Criteria
i.) Cancer patient about to complete (+/- 2d) a course of radiotherapy
ii.) Ability to understand and complete the questionnaire
iii.) > 18 years
iv.) Patient gave informed consent
Exclusion Criteria
i.) Patient has already participated in the study for another course of radiotherapy
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method • Confirmation of the prevalence of financial toxicity based on a previous study per EORTC QLQ-C30 q28 (subjective financial distress) and Confirmation of risk factors for financial toxicity based on a previous study
- Secondary Outcome Measures
Name Time Method Exploration of additional variables as risk factors for financial toxicity (e.g. distress, duration of radiotherapy) and Association of financial toxicity and patient satisfaction